Sunday, February 15, 2026 2/15/2026

Correlating mechanical and genetic data at high-throughput and single cell levels to investigate metastasis

Award Number: F31CA243345
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 07/01/2021
PERIOD OF PERFORMANCE END DATE: 12/31/2021

Group Awards By:

View Award Description

Correlating mechanical and genetic data at high-throughput and single cell levels to investigate metastasis - Metastasis is the cause of 90% of cancer-related deaths, a statistic that has changed little over the past 50 years. During that time, cancer researchers have recognized that changes in cells’ mechanical phenotypes dictate their ability to generate force, invade through tissues and migrate throughout the body. Several studies have implicated that as a cell’s metastatic potential increases, cell stiffness decreases. More generally, the relationship between disease state and cell mechanics suggests that changes in cell stiffness are correlated with phenotypes of invasiveness, migration, epithelial-to-mesenchymal transition (EMT), and metastasis and are controlled through various cell-signaling networks. Yet while certain genes that affect cell mechanics have been studied, a genome-wide study of genes and gene networks that modulate cell biophysical properties has not been attempted. The use of genome-wide CRISPR knockout (GeCKO) pooled screens has allowed researchers to start exploring the connection between a cell’s genotype and various phenotypes. To understand gene networks that control cell mechanics and their role in metastatic potential, we will need to uncover the genetic molecular mechanisms that allow cells to change their mechanical properties to successfully form a metastatic tumor. The long-term goal of this research is to understand the molecular and mechanical mechanisms driving metastasis that will lead to the discovery of new diagnostics and therapeutic targets to find and stop key processes of metastatic cells. To reach this goal, we will leverage a novel microfluidics approach for cell sorting based upon biophysical properties for the high-throughput discovery of genes linked to cell mechanics and metastasis. We will use this approach to determine how cellular mechanics are regulated within the context of networks of cytoskeletal and structural proteins in addition to various transcription factors and signaling proteins associated with increased metastatic potential. I will investigate this intersection with the following aims: 1) Identify genes related to mechanical changes in cancer cells through GeCKO high- throughput mechanical screen and 2) Validate phenotypic and mechanotypic importance of genes of interest. We hypothesize that there is a link between cell softening and mesenchymal, migratory phenotypes that is controlled by the expression of a network of genes of interest. The proposed studies will represent the first attempt to evaluate the entire genome for its role in directing cell mechanics to understand the connection between cancer cell genotype, phenotype and mechanotype both across the whole genome and on the single cell level. Being able to collect information about the combination of gene expression data and cell stiffness measurements in a high throughput fashion and an in-depth exploration of genes related to mechanics and metastatic potential will lead to great advancement of our understanding of the metastatic cascade with potential application in many other fields where cell mechanics play a role in disease state.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = -$5,615 )
2023	2021	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30332	FULTON	USA	Cancer Research Manpower	002	2	1/19/2023	SUPPLEMENT FOR EXPANSION	-$5,615
2023	2020	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30332	FULTON	USA	Cancer Research Manpower	001	2	1/19/2023	NON-COMPETING CONTINUATION	$0
2023	2019	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30332	FULTON	USA	Cancer Research Manpower	000	1	1/19/2023	NEW	$0
														Subtotal = -$5,615

Issue Date FY: 2021 ( Subtotal = $20,623 )
2021	2021	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30332	FULTON	USA	Cancer Research Manpower	001	2	9/14/2021	SUPPLEMENT FOR EXPANSION	$20,623
2021	2020	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30332	FULTON	USA	Cancer Research Manpower	000	2	9/13/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $20,623

Issue Date FY: 2020 ( Subtotal = $45,520 )
2020	2020	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30318	FULTON	USA	Cancer Research Manpower	000	2	6/30/2020	NON-COMPETING CONTINUATION	$45,520
														Subtotal = $45,520

Issue Date FY: 2019 ( Subtotal = $45,016 )
2019	2019	GEORGIA TECH RESEARCH CORPORATION	505 10TH ST NW	ATLANTA	GA	30318	FULTON	USA	Cancer Research Manpower	001	1	6/26/2019	NEW	$0
2019	2019	GEORGIA TECH RESEARCH CORPORATION	505 10TH ST NW	ATLANTA	GA	30318	FULTON	USA	Cancer Research Manpower	000	1	6/26/2019	NEW	$45,016
														Subtotal = $45,016

Grand Total All Awards = $105,544

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Correlating mechanical and genetic data at high-throughput and single cell levels to investigate metastasis

Award Number: F31CA243345

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 07/01/2021

PERIOD OF PERFORMANCE END DATE: 12/31/2021

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer